Cargando…

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698599/ https://www.ncbi.nlm.nih.gov/pubmed/31616169 http://dx.doi.org/10.2147/DMSO.S225508

Ejemplares similares

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
por: Wilke, Thomas, et al.
Publicado: (2019)

Corrigendum to “Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran” [Data in Brief 18 (2018) 2047–2050]
por: Mostafavian, Zahra, et al.
Publicado: (2018)

Corrigendum to “Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea”
por: Wang, Xiaoya, et al.
Publicado: (2018)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Publicado: (2017)

Corrigendum to “Impact of Diabetic Ketoacidosis on Thyroid Function in Patients with Diabetes Mellitus”
por: Xing, Yuling, et al.
Publicado: (2021)

Corrigendum: Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction
por: Park, Kyu-Hwan, et al.
Publicado: (2018)

Corrigendum: Author ORCID Number Correction. Dietary Sodium Intake in Patients with Type 2 Diabetes Mellitus
por: Kim, Mi-Kyung
Publicado: (2017)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigendum to “The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction”
por: Afanasiev, S. A., et al.
Publicado: (2019)

Corrigendum: Efficacy of Real world Entecavir Therapy in Treatment NaïveChronic Hepatitis B Patients
Publicado: (2017)

Corrigendum to “Correlation between lower extremity arterial disease and skeletal muscle mass in patients with type 2 diabetes mellitus”
Publicado: (2020)

Corrigendum: Ethical issue related to "Blood glucose levels, insulin concentrations, and insulin resistance in healthy women and women with premenstrual syndrome: A comparative study"
por: Zarei, Safar, et al.
Publicado: (2013)

Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
por: Iqbal, Ahmed, et al.
Publicado: (2018)

Corrigendum to “GC Method Validation for the Analysis of Menthol in Suppository Pharmaceutical Dosage Form”
por: Abualhasan, Murad N., et al.
Publicado: (2018)

Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study
por: Wu, Jianmin, et al.
Publicado: (2021)

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”
por: Tang, Ruiqi, et al.
Publicado: (2021)

Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke [Corrigendum]
Publicado: (2022)

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum]
Publicado: (2018)

Corrigendum to “Effect of Intervention in Subjects with High Risk of Diabetes Mellitus in Pakistan”
por: Hydrie, Muhammad Zafar Iqbal, et al.
Publicado: (2015)

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
por: Godman, Brian, et al.
Publicado: (2023)

Corrigendum: Author's Name and Affiliation Correction. The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
por: AminiLari, Zeinab, et al.
Publicado: (2017)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
por: TSAI, Shih-Tzer, et al.
Publicado: (2011)

Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Corrigendum to “Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes”
por: Mohd-Radzman, Nabilatul Hani, et al.
Publicado: (2016)

Corrigendum to “The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway”
por: Cai, Yu, et al.
Publicado: (2018)

Corrigendum to “Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes”
por: Mottalib, Adham, et al.
Publicado: (2016)

Corrigendum to: Resveratrol Exerts Dosage-Dependent Effects on the Self-Renewal and Neural Differentiation of hUC-MSCs
por: Wang, Xinxin, et al.
Publicado: (2020)

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
por: Duque, Natalia, et al.
Publicado: (2021)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
Publicado: (2017)

Corrigendum to “Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes”
por: Fu, Yuanyuan, et al.
Publicado: (2022)

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience [Corrigendum]
Publicado: (2014)

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Polysaccharide Peptide (PsP) Ganoderma lucidum: A Potential Inducer For Vascular Repair In Type 2 Diabetes Mellitus Model [Corrigendum]
Publicado: (2019)

General Theory of Inflammation: Patient Self-Administration of Hydrocortisone Safely Achieves Superior Control of Hydrocortisone-Responding Disorders by Matching Dosage with Symptom Intensity [Corrigendum]
Publicado: (2020)

General Theory of Inflammation: Patient Self-Administration of Hydrocortisone Safely Achieves Superior Control of Hydrocortisone-Responding Disorders by Matching Dosage with Symptom Intensity [Corrigendum]
Publicado: (2023)

Corrigendum to ‘Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities’
por: Takamura, Toshinari, et al.
Publicado: (2017)

Background Factors Determining the Introduction and Dosage of Insulin in Women With Gestational Diabetes Mellitus
por: Matsumoto, Yuko, et al.
Publicado: (2019)

Corrigendum to “Old and New NICE Guidelines for the Evaluation of New Onset Stable Chest Pain: A Real World Perspective”
por: Carrabba, Nazario, et al.
Publicado: (2019)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Corrigendum to “Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence study”
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bvmdhdt6dntqb81pr9sl4i5bo1